Endocrine Screening Methods Workshop report: Detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms

Reproductive Toxicology

Volumn 11, Issue 5, 1997, Pages 719-750

  Earl Gray Jr , L ^q   Kelce, William R ^r   Wiese, Tom ^r   Tyl, Rochelle ^a   Gaido, Kevin ^b   Cook, Jon ^c   Klinefelter, Gary ^r   Desaulniers, Daniel ^d   Wilson, Elizabeth ^e   Zacharewski, Tim ^f   Waller, Chris ^r   Foster, Paul ^b   Laskey, John ^r   Reel, Jerry ^g   Giesy, John ^h   Laws, Susan ^r   McLachlan, John ⁱ   Breslin, William ^j   Cooper, Ralph ^r   Di Giulio, Richard ^k   Johnson, Rodney ^r   Purdy, Richard ^l   Mihaich, Ellen ^m   Safe, Stephen ⁿ   Sonnenschein, Carlos ^o   Welshons, Wade ^o   Miller, Ron ^j   McMaster, Suzanne ^r   Colborn, Theo ^p   more..

^a RTI INTERNATIONAL   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^c DUPONT COMPANY   (United States)

^d Health and Welfare   (Canada)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g BIOQUAL INC   (United States)

^h MICHIGAN STATE UNIVERSITY   (United States)

ⁱ TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j DOW CHEMICAL COMPANY   (United States)

^k DUKE UNIVERSITY   (United States)

^l 3M COMPANY   (United States)

^m Rhone Poulenc Ag Company   (United States)

ⁿ TEXAS A AND M UNIVERSITY   (United States)

^o TUFTS UNIVERSITY   (United States)

^p WORLD WILDLIFE FUND   (United States)

^q U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^r NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ENZYME; ESTROGEN; ESTROGEN RECEPTOR; HORMONE ANTAGONIST; STEROID RECEPTOR;

ANIMAL; CONFERENCE PAPER; ENDOCRINE FUNCTION TEST; ESTROGEN ACTIVITY; FEMALE; GOVERNMENT; HORMONE ACTION; HUMAN; MALE; METABOLISM; METHODOLOGY; RECEPTOR BINDING; SCREENING TEST; TOXICITY TESTING; UNITED STATES;

ANDROGENS; ANIMALS; ENZYMES; ESTROGENS; FEMALE; HORMONE ANTAGONISTS; HUMANS; MALE; RECEPTORS, STEROID; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 0000947944     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)00025-7     Document Type: Conference Paper

References (180)

1. 1. Kavlock R, Daston G, DeRosa C, et al. Research needs for risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored Workshop. Environ Health Perspect. 1996:104:715-40.
2. 2. Gillman AG et al. Goodman & Gillman's The Pharmacological basis of therapeutics. 8th ed. MacMillian: 1990.
3. 3. Allegretto E, Heyman R. Intracellular receptor characterization and ligand screening by transactivation and hormone-binding assays. Methods Mol Genet 1996;8:405-20.
4. 4. Allen E, Doisy E. The induction of a sexually mature condition in immature females by injection of the ovarian follicular hormone. Am J Physiol 1924;69:577.
5. 5. Hershberger L, Shipley E, Meyer R. Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc Soc Exp Biol Med 1953;83:175.
6. 6. Reel J, Lamb J, Neal B. Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam Appl Toxicol. 1996;34:288-305.
7. 7. Parker A. ed. Marshalls Physiology of Reproduction. London: Longmans Green and Co. Ltd.; 1966.
8. 8. Dodds E, Lawson W, Noble R. Biological effects of the synthetic oestrogenic substance 4:4′-dihydroxy-α:B-diethylstilbene. Lancet 1938;139:627.
9. 9. Laws S, Carey S, Huey O, Gray LE. 4-Tert-octylphenol: in vitro and in vivo assessments of potential estrogenicity in rats. Toxicologist 1995;30:132.
10. 10. Gray LE Jr, Ostby J, Ferrell J, et al. A dose-response analysis of methoxychlor-induced alterations of reproductive development and function in the rat. Fundam Appl Toxicol. 1989;12:92-108.
11. 11. Gillesby B, Zacharewski T. Endocrine disrupters: mechanism of action of promiscuous receptors and strategies for identification and assessment [abstract]. Proceedings of 17th Annual Society of Environmental Toxicology and Chemistry. 1996;006.
12. 12. Gray LE. Organizational and activational effects of pesticides and toxic substances on the CNS and behavior: endocrine versus nonendocrine mechanisms. Toxicol Ind Health. In press.
13. 13. Reel J, Lawton A, Wolkowski-Tyl R, Davis G, Lamb J. Evaluation of a new reproductive toxicology protocol using diethylstilbestrol (DES) as a positive control compound. J Am Coll Toxicol. 1985;4:147.
14. 14. Conner J, Cook J, Craven C, Van Pelt C, Obourn J. An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. Fundam Appl Toxicol. 1996;33:188-95.
15. 15. Salamon V. The effect of testosterone propionate on the genital tract of the immature female rat. Endocrinology. 1938;23:779-83.
16. 16. Nelson K, Takahashi T, Bossert N, Walmer D, McLachlan J. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc Natl Acad Sci. 1991;88:21-5.
17. 17. Heywood R, Wadsworth P. The experimental toxicology of estrogens. Pharmacol Ther. 1980;8:125-42.
18. 18. Morali G, Beyer C. Neuroendocrine control of mammalian estrous behavior. In: Beyer C, ed. Endocrine control of sexual behavior. New York: Raven Press; 1979:33-75.
19. 19. Larsson K. Features of the neuroendocrine regulation of masculine sexual behavior. In: Beyer C, ed. Endocrine control of sexual behavior. New York: Raven Press; 1979:77-163.
20. 20. Young W, Fish W. The ovarian hormones and spontaneous running activity in the female rat. Endocrinology. 1945;36:181-9.
21. 21. Gray LE Jr, Ostby J, Ferrell J, Goldman J. Methoxychlorinduced alterations of estrogen-dependent running wheel activity: the reproductive tract and pituitary function in the female rat. Toxicol Appl Pharmacol. 1988;96:525-40.
22. 22. Miyazaki K, Dambrosia J, Kebabian J. Dopaminergic modulation of DES-induced proliferation of the anterior pituitary of the Fisher 344 rat. Neuroendocrinology. 1985;41:405-8.
23. 23. Anderson S, Pearce S, Fail P, McTaggert B, Tyl R, Gray LE. Validation of the alternative reproductive test protocol (ART) to assess toxicity of methoxychlor in rats. Toxicologist. 195;15:164.
24. 24. Toppari J, Larsen J, Christiansen P, et al. Male reproductive health and environmental xenoestrogens. Envison Health Perspect. 1996;104:741-803.
25. 25. Robaire B, Ewing L, Irby DC, Desjardins C. Interactions of testosterone and estradiol-17β on the reproductive tract of the male rat. Biol Reprod. 1979;21:455-63.
26. 26. Arai Y, Mori T, Suzuki Y, Bern H. Long-term effects of perinatal exposure to sex steroids and diethylstilbestrol on the reproductive system of male mammals. Int Rev Cytol. 1983;84:235-68.
27. 27. Iguchi T. Cellular effects of early exposure to sex hormones and antihormones. Int Rev Cytol. 1992;139:1-55.
28. 28. Schardein JL. Hormones and hormonal antagonists. In: Schardein, ed. Chemically induced birth defects. New York: Marcel Dekker; 1993:271-339.
29. 29. Sheehan D. The case for expanded phytoestrogen research. Proc Soc Exp Biol Med. 1995;208:3-5.
30. 30. Medlock K, Branham W, Sheehan D. The effects of phytoestrogens on neonatal rat growth and development. Proc Soc Exp Biol Med. 1995;208:307-13.
31. 31. Gorski RA, Gordon JH, Shryne JE, Southam AM. Evidence for a morphological sex difference within the medial preoptic area of the rat brain. Brain Res. 1978;148:333-46.
32. 32. Gray LE, Monosson E, Kelce W. Emerging issues: the effects of endocrine disrupters on reproductive development. In: Di Guilio R, Monosson E, eds. Interconnections between human and ecosystem health. London: Chapman and Hall; 1996:45-82.
33. 33. Heinrichs WL, Gellert RJ, Bakke JL, Lawrence NL. DDT administered to neonatal rats induces persistent estrus syndrome. Science. 1971;173:642-3.
34. 34. Gellert RJ. Kepone, mirex, dieldrin and aldrin: estrogenic activity and the induction of persistent vaginal estrus and anovulation in rats following neonatal treatment. Environ Res. 1978;16:131-8.
35. 35. Gellert RJ, Wilson C. Reproductive function in rats exposed prenatally to pesticides and polychlorinated biphenyls (PCB). Environ Res. 1979;18:437-43.
36. 36. Gellert RJ. Uterotrophic activity of polychlorinated biphenyls and induction of precocious reproductive aging in neonatally treated female rats. Environ Res. 1978;16:123-30.
37. 37. Harris M, Chapin R, Haskins J, et al. The effects of perinatal/ juvenile pesticide exposure on adult reproductive performance. Toxicologist. 1996;30:144.
38. 38. Gray LE Jr. Neonatal chlordecone exposure alters behavioral sex differentiation in female hamsters. Neurotoxicology. 1982;3(2): 67-80.
39. 39. Gellert RJ, Heinrichs WL, Swerdloff R. Effects of neonatally-administered DDT homologs on reproductive function in male and female rats. Neuroendocrinology. 1974;16:84-94.
40. 40. Chapin R, Harris M, Shelby M, Smialowicz R, Moser V, Padilla S, MacPhail R, Berone S. The effects of perinatal/juvenile pesticide exposure on adult CNS: immune and reproductive function in rats. Toxicologist. 1996;30:52.
41. 41. Vom Saal F. Effects of exposure to estrogenic chemicals during fetal life on the reproductive system of male mice [abstract]. International School of Ethology 11th Workshop: Environmental Endocrine Disrupting Chemicals. Erice, Sicily. 1995.
42. 42. Ramirez V, Sawyer C. Advancement of puberty in the female rat by estrogen. Endocrinology. 1964;76:1158-68.
43. 43. Hannon W, Hill F, Bernert J, et al. Premature thelarche in Puerto Rico: a search for environmental estrogenic contamination. Arch Environ Contam Toxicol. 1987;16:255-62.
44. 44. Shaban M, Terranova P. 2-Bromo-α-ergocryptine mesylate (CB-154) inhibits prolactin and luteinizing hormone secretion in the prepubertal female rat. Biol Reprod. 1986;34:788-95.
45. 45. Gonzalez MD, Lopez F, Aguilar E. Involvement of prolactin in the onset of puberty in female rats. J Endocrinol. 1984;101:63-8.
46. 46. Hostetter M, Piacsek B. The effect of prolactin deficiency during sexual maturation in the male rat. Biol Reprod. 1977;17:574-7.
47. 47. Ramely J, Phares C. Delay of puberty onset in males due to suppression of growth hormone. Neuroendocrinology. 1983;36: 321-9.
48. 48. Gray LE, Kelce WR, Monosson E, Ostby JS, Birnbaum LS. Exposure to TCDD during development permanently alters reproductive function in male LE rats and hamsters: reduced ejaculated and epididymal sperm numbers and sex accessory gland weights in offspring with normal androgenic status. Toxicol Appl Pharmacol. 1995;131:108-18.
49. 49. Bjerke D, Peterson R. Reproductive toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male rats: different effects of in utero versus lactational exposure. Toxicol Appl Pharmacol. 1994;127: 241-9.
50. 50. Gray LE, Ostby J, Wolf C, et al. Functional developmental toxicity of low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin and a dioxin-like PCB (169) in Long Evans rats and Syrian hamsters: reproductive, behavioral and thermoregulatory alterations. Organohalogen Compounds. 1995;25:33-8.
51. 51. Korenbrot CC, Huhtaniemi I. Weiner R. Preputial separation as an external sign of pubertal development in the male rat. Biol Reprod. 1977;17:298-303.
52. 52. Johnson D, Kogo H, Sen M, Dey S. Multiple estrogenic action of o,p′-DDT: initiation and maintenance of pregnancy in the rat. Toxicology. 1988;53:79-87.
53. 53. Astwood W. As assay method for progesterone based upon the decidual reaction in the rat. J Endocrinol. 1939;1:49.
54. 54. Cummings A. Toxicological mechanisms of implantation failure. Fundam Appl Toxicol. 1990;15:571-9.
55. 55. Cummings A, Gray LE. Antifertility effects of methoxychlor in female rats. A time-dependent blockade of pregnancy. Toxicol Appl Pharmacol. 1989;97:454-62.
56. 56. Anderson J, Clark JH, Peck EJ Jr. Oestrogen and nuclear binding sites. Determination of specific sites by [3H]oestradiol exchange. Biochem J. 1972;126:561-7.
57. 57. Korach KS. Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor systems. Endocrinology. 1979;104:1324-32.
58. 58. Chae K, Gibson MK, Korach K. Estrogen receptor sterochemistry: Ligand binding orientation and influence on biological activity Mol Pharmacol. 40:806-811.
59. 59. Soule HD, Vazquez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973;51:1409-16.
60. 60. Brooks SC, Locke ER, Soule HD. Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem. 1973;248: 6251-3.
61. 61. Horwitz KB, Costlow ME, McGuire WL. MCF-7: a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids. 1975;26:785-95.
62. 3 receptor in a cultured human breast cancer cell line (MCF-7 cells). Biochem Biophys Res Commun. 1980;93:9-15.
63. 63. Takenawa T, Ueda H, Millan JC, Brandes D. Retinoic acid-binding protein in a human cell (MCF-7) from breast carcinoma. Lab Invest. 1980;42:490-4.
64. 64. Taylor CM, Blanchard B, Zava DT. A simple method to determine whole cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer culture. J Steroid Biochem. 1984;20:1083-8.
65. 65. Kurebayashi J, Horiuchi R, Nakamura T, et al. Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method [Japanese]. Nippon Naibunpi Gakkai Zasshi - Folia Endocrinologica Japonica. 1987;63:1351-63.
66. 66. Shafie S, Brooks SC. Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations. J Lab Clin Med. 1979;94:784-98.
67. 67. MacIndoe JH, Woods GR. Steroid-metabolizing enzymes in human breast cancer cells. II. 5α-Reductase, 3α-hydroxysteroid oxidoreductase, and 17 β-hydroxysteroid oxidoreductase. Endocrinology. 1981;108:1407-13.
68. 68. MacIndoe JH, Hinkhouse M. Wood G. Dehydroepiandrosterone and estrone 17-ketosteroid reductases in MCF-7 human breast cancer cells. Breast Cancer Res Treat. 16:261-72.
69. 69. Lippman M, Bolan G, Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976;36:4595-601.
70. 70. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 1995;103(Suppl 7):113-22.
71. 71. Welshons WV, Rottinghaus GE, Nonneman DJ, Dolan-Timpe M, Ross PF. A sensitive bioassay for detection of dietary estrogens in animal feeds. J Vet Diagn Invest. 1990;2:268-73.
72. 72. Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonylphenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect. 1991;92:167-73.
73. 73. Mayr U, Butsch A, Schneider S. Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. Toxicology. 1992;74:135-49.
74. 74. Wakeling AK, Bowler J. Novel antioestrogens without partial agonist activity. J Steroid Biochem. 1988;31:645-53.
75. 75. Wakeling AK, Newboult E, Peters SW. Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells. J Mol Endocrinol. 1989;2:225-34.
76. 76. Jain PT, Pento JT. Growth medium for the evaluation of antiestrogenic compounds in MCF-7 cell culture. Methods Find Exp Clin Pharmacol. 1991;13:595-8.
77. 77. Wakeling AE, Bowler J. ICI 182,780, a new antioestrogen with clinical potential. J Steroid Biochem Mol Biol. 1992;43:173-7.
78. 78. Wiese TE, Kral LG, Dennis KE, Butler WB, Brooks SC. Optimization of estrogen growth response in MCF-7 cells. In Vitro Cell Dev Biol. 1992;28A:595-602.
79. 79. Dell' Aquila ML, Pigott DA, Bonaquist DL, Gaffney EV. A factor from plasma-derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification. J Natl Cancer Inst. 1984;72:291-8.
80. 80. Soto AM, Sonnenschein C. Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells. Biochem Biophys Res Commun. 1984;122:1097-103.
81. 81. Soto AM, Silvia RM, Sonnenschein C. A plasma-borne specific inhibitor of the proliferation of human estrogen-sensitive breast tumor cells (estrolycone-I). J Steroid Biochem Mol Biol. 1992; 43:703-12.
82. 82. Aakvaag A, Utaaker E, Thorsen T, Lea OA, Lahooti H. Growth control of human mammary cancer cells (MCF-7 cells) in culture: effect of estradiol and growth factors in serum-containing medium. Cancer Res. 1990;50:7806-10.
83. 83. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res. 1987;47:4355-60.
84. 84. Welshons WV, Jordan VC. Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. Eur J Cancer Clin Oncol. 1987;23:1935-9.
85. 85. Nawata H, Chong MT, Bronzen D, Lippman ME. Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture. J Biol Chem. 1981;256:6895-902.
86. 86. Vickers PJ, Dickson RB, Shoemaker R, Cowan KH. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone independent tumor growth in vivo. Mol Endocrinol. 1988;2:886-92.
87. 87. Kitawaki J, Kim T, Kanno H, Noguchi T, Yamamoto T, Okada H. Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening. J Steroid Biochem Mol Biol. 1993;44:667-70.
88. 88. Sonnenschein C, Szelei J, Nye TL, Soto AM. Control of cell proliferation of human breast MCF7 cells: serum and estrogen resistant variants. Oncol Res. 1994;6:373-81.
89. 89. Villalobos M, Olea N, Brotons JA, Olea-Serrano MF, Ruiz de Almodovar JM, Pedraza V. The E-screen assay: a comparison of different MCF7 cell stocks. Environ Health Perspect. 1995;3: 844-50.
90. 90. Masamura S, Santner SJ, Heitjan DF, Santen RJ. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab. 1995;80:2918-25.
91. 91. Klotz DM, Castles CG, Fuqua SA, Spriggs LL, Hill SM. Differential expression of wild-type and variant ER mRNAs by stocks of MCF-7 breast cancer cells may account for differences in estrogen responsiveness. Biochem Biophys Res Commun. 1995;210:609-15.
92. 92. Devleeschouwer N, Legros N, Olea-Serrano N, Paridaens R, Leclercq G. Estrogen conjugates and serum factors mediating the estrogenic trophic effect on MCF-7 cell growth. Cancer Res. 1987;47:5883-7.
93. 93. Welshons WV, Grady LH, Engler KS, Judy BM. Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum. Breast Cancer Res Treat. 1992;23:97-104.
94. 94. Butler WB. Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle. Anal Biochem. 1984;141:70-3.
95. 95. Mellanen P, Petanen T, Lehtimaki J, et al. Wood-derived estrogens: studies in vitro with breast cancer cell lines and in vivo in trout. Toxicol Appl Pharmacol. 1996;136:381-8.
96. 96. Aitken SC, Lippman ME, Kasid A, Schoenberg DR. Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells. Cancer Res. 1985;45:2608-15.
97. 97. Jain PT, Pento JT, Graves DC. Cell-growth quantitation methods for the evaluation of antiestrogens in human breast cancer cells in culture. J Pharmacol Toxicol Methods. 1992;27:203-7.
98. 98. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving [see comments]. Endocrinology. 1993;132:2279-86.
99. 99. VanderKuur JA, Wiese T, Brooks SC. Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex. Biochemistry. 1993;32:7002-8.
100. 100. Pilat MJ, Hafner MS, Kral LG, Brooks SC. Differential induction of pS2 and cathepsin D mRNAs by structurally altered estrogens. Biochemistry. 1993;32:7009-15.
101. 101. Davis MD, Butler WB, Brooks SC. Induction of tissue plasminogen activator mRNA and activity by structurally altered estrogens. J Steroid Biochem Mol Biol. 1995;52:421-30.
102. 102. Nunez A, Berry M, Imler J, Chambon P. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumor promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J. 1989;8: 823-29.
103. 103. Cavailles V, Garcia M, Rochefort H. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF-7 human breast cancer cells. Mol Endocrinol. 1989;3:552-8.
104. 104. Zacharewski TR, Bondy KL, McDonell P, Wu ZF. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res. 1994;54:2707-13.
105. 105. VanderKuur JA, Hafner MS, Christman JK, Brooks SC. Effects of estradiol-17β analogues on activation of estrogen response element regulated chloramphenicol acetyltransferase expression. Biochemistry 1993;32:7016-21.
106. 106. Meyer T, Koop R, von Angerer E, Schonenberger H, Holler E. A rapid luciferase transfection assay for transcription activation effects and stability control of estrogens in cell cultures. J Cancer Res Clin Oncol. 1994;120:359-64.
107. 107. Ince BA, Montano MM, Katzenellenbogen BS. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′-monophosphate and ligands including antiestrogens. Mol Endocrinol. 1994;8:1397-1406.
108. 108. Katzenellenbogen BS, Montano MM, Le Goff P, et al. Antiestrogens: mechanisms and actions in target cells. J Steroid Biochem Mol Biol. 1995;53:387-3.
109. 109. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994;63:451-86.
110. 110. Zacharewski T. A review of in vitro bioassays for assessing estrogenic substances. Environ Sci Technol. In Press.
111. 111. Ruh MF, Zacharewski T, Connor K, Howell J, Chen I, Safe S. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem Pharmacol. 1995;50:1485-93.
112. 112. Zacharewski T, Berhane K, Gillesby B, Burnison BK. Evidence for the presence of estrogen receptor and Ah receptor ligands in pulp and paper mill black liquor. Environ Sci Technol. 1995;29: 2140-6.
113. 113. Connor K, Howell J, Chen I, Berhane K, Sciarretta C, Safe S, Zacharewski T. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol. 1996;30:93-101.
114. 114. Moore M, Mustain M, Daniel K, Chen I, Safe S, Zacharewski T. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Toxicol Appl Pharmacol. 1997;142:160-8.
115. 115. Balaguer P, Joyeux A, Denison MS, Vincent R, Gillesby BE, Zacharewski T. Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures using in vitro recombinant receptor-reporter gene assays. Can J Physiol Pharmacol. 1996;74:216-22.
116. 116. Pons M, Gagne D, Nicolas JC, Mehtali M. A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques. 1990;9:450-9.
117. 117. Gagne D, Balaguer P, Demirpence E, et al. Stable luciferase transfected cells for studying steroid receptor biological activity. J Biolumin Chemilumin. 1994;9:201-9.
118. 118. Metzger D, White JH, Chambon P. The human oestrogen receptor functions in yeast. Nature. 1988;334:31-6.
119. 119. Schena M, Yamamoto KR. Mammalian glucocorticoid receptor derivatives enhance transcription in yeast. Science. 1988;241: 965-7.
120. 120. McDonnell DP, Pike JW, Drutz DJ, Butt TR, O'Malley BW. Reconstitution of the vitamin D-responsive osteocalcin transcription unit in Saccharomyces cerevisiae. Mol Cell Biol. 1989;9: 3517-23.
121. 121. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ, Mclachlan JA. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science. 1996;272: 1489-92.
122. 122. Gaido KW, Leonard LS, Lovell S, et al. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol. 1997;143:205-12.
123. 123. Kohno H, Gandidi O, Curtis SW, Korach KS. Anti-estrogen activity in the yeast transcription system: estrogen receptor mediated agonist response. Steroids. 1994;572-8.
124. 124. Arnold SF, Robinson MK, Notides AC, Guillette LJ, Mclachlan JA. A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environ Health Perspect. 1996;104:544-8.
125. 125. Desbrow C, Waldock M, Sheahan D, et al. The identification of compounds causing endocrine disruption in fish in UK rivers. 17th Annual Society of Environmental Toxicology and Chemistry Abstract. 1996:190.
126. 126. Krall A, Yamamoto KR. An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J Biol Chem. 1996;271:17152-6.
127. 127. Cramer RDI, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier Proteins. J Am Chem Soc. 1988;110:5959-67.
128. 128. Clark M, Cramer RD, Jones DM, Patterson DE, Simeroth PE. Comparative Molecular Field Analysis (CoMFA). 2. Toward its use with 3D-Structural Databases. Tetrahedron Comp Methods. 1990;3:47-59.
129. 129. Waller CL, Minor DL, McKinney JD. Using three-dimensional quantitative structure-activity relationships to examine estrogen receptor binding affinities of polychlorinated hydroxybiphenyls. Environ Health Perspect. 1995;103:702-7.
130. 130. Waller CL, Juma BW, Gray LE, Kelce WR. Three-dimensional quantitative structure-activity relationships for androgen receptor ligands. Toxicol Appl Pharmacol. 1996;137:219-27.
131. 131. Waller CL, Oprea TI, Chae K, et al. Ligand-based identification of environmental estrogens. Chem Res Toxicol. 1996;9:1240-8.
132. 132. Wiese TE, Polin LA, Palomino E, Horwitz JP, Brooks SC. Induction of the estrogen specific mitogenic response in MCF-7 cells by selected analogues of estradiol-17β: a 3D QSAR study. 25th National Medicinal Chemistry Symposium, Ann Arbor, MI [Abstract]. 1996:24.
133. 133. Kelce WR, Monosson E, Gamesik MP, Laws SC, Gray LE Jr. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol. 1994;126:275-85.
134. 134. Gray LE Jr, Ostby J, Kelce WR. Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rats. Toxicol Appl Pharmacol. 1994; 129:46-52.
135. 135. Gray LE, Kelce WR. Latent effects of pesticides and toxic substances on sexual differentiation of rodents. Toxicol Indust Health. 1996;12:515-31.
136. 136. Kelce WR, Stone C, Laws S, Gray LE, Kemppainen J, Wilson E. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature. 1995;375:581-5.
137. 137. Spencer J, Torrado T, Sanchez R, Vaughn E, Imperato-McGinley J. Effects of flutamide and finasteride on rat testicular descent. Endocrinology. 1991;129:741-8.
138. 138. Vom Saal F, Montano M, Wang M. Sexual differentiation in mammals. In: Colborn T, Clement C, eds. Advances in modern environmental toxicology. Vol XXI. Chemically-induced alterations in sexual and functional development: the wildlife/human connection. Princeton: Princeton Scientific Publishing Co. Inc.; 1992:203-30.
139. 139. Gupta C, Siegel S, Ellis E. The role of EGF in testosterone-induced reproductive tract differentiation. Dev Biol. 1991;146: 106-16.
140. 140. Anderson S, Pearce S, Fail P, McTaggert B, Tyl R, Gray LE. Testicular and adrenal response in adult Long-Evans Hooded rats after antiandrogenic vinclozolin exposure. J Androl. 1995;16:43.
141. 141. Kelce W, Lambright C, Gray LE, Roberts K. Vinclozolin and p,p′-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor mediated mechanism. Toxicol Appl Pharmacol. 1997;142:192-200.
142. 142. Huhtaniemi I, Amsterdam A, Naor Z. Effect of postnatal treatment with agonadotropin-releasing hormone antagonist on sexual maturation of male rats. Biol Reprod. 1986;35:501-7.
143. 143. Edgren R. Issues in animal pharmacology. In: Goldzieher J, Fotherby K, eds. Pharmacology of the contraceptive steroids. New York: Raven Press, Ltd.; 1994:81-98.
144. 144. Luke M, Coffey D. The male sex accessory tissues. In: Knobil E, Neill J, eds. The physiology of reproduction. 2nd ed. New York: Raven Press; 1994:1435-88.
145. 145. Fail P, Pearce S, Anderson S, Tyl R, Gray LE. Endocrine and reproductive toxicity of vinclozolin in male Long-Evans hooded rats. Toxicologist. 1995;15:293.
146. 146. Wilson EM, French FS. Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis and prostate. J Biol Chem. 1976;25:5620-9.
147. 147. Yarbrough WG, Quarmby VE, Simental JA, et al. A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J Biol Chem. 1990;265: 8893-900.
148. 148. Zhou ZX, Sar M, Simental JA, Lane MV, Wilson E. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. J Biol Chem. 1994;269:13115.
149. 149. Wong C-I, Kelce WR, Sar M, Wilson E. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J Biol Chem. 1995;270:19998-20003.
150. 150. Purvis IJ, Chotai D, Dykes CW, Lubahn DB, French FS, Wilson EM, Hobden AN. An androgen-inducible expression system for Saccharomyces cerevisiae. Gene. 1991;106:35-42.
151. 151. Taton M, Ullmann P, Benveniste P, Rahier A. Interaction of Triazole fungicides and plant growth regulators with microsomal cytochrome D-450-dependent obtusifoliol 14α-Methyl Demethylase. Pestic Biochem Physiol. 1988;30:178-189.
152. 152. Murray M, Reidy G. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol Rev. 1990; 42:85-101.
153. 153. Classer S, Northcutt R, Chytil F, Schott C. The influence of an antisteroidogenic drug (aminoglutethimide phosphate) on pregnancy maintenance. Endocrinology. 1972;90:1363-70.
154. 154. Goldman AS, Eavey RD, Baker MK. Production of male pseudohermaphroditism in rats by two new inhibitors of steroid 17α-hydroxylase and C17-20 lyase. J Endocrinol. 1976;71:289-97.
155. 155. Milne C, Hasmall R, Russell A, Watson S, Vaughan Z, Middleton M. Reduced estradiol production by a substituted triazole results in delayed ovulation in rats. Toxicol Appl Pharmacol. 1987;90: 427-35.
156. 156. Tayeb E, Salih Y, Pillay A. Effects of aminoglutethimide on ovarian histology in the rat. Acta Anat. 1985;122:212-5.
157. 157. Schurmeyer T, Nieschlag E. Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis. Acta Endocrinol. 1984;105:275-80.
158. 158. Pepper G, Brenner S, Gabrilove J. Ketoconazole use in the treatment of ovarian hyperandrogenism. Fertil Steril. 1990;54: 438-44.
159. 159. Higashi Y, Yoshida K, Oshima H. In vitro inhibition by ketaconazole of human testicular steroid oxidoreductases. J Steroid Biochem. 1990;36:667-71.
160. 160. Gray LE Jr, Kelce WR, Laskey J. Pesticides affect mammalian reproductive development and function via multiple mechanisms of action [abstract presented at Wingspread Conference on contemporary use pesticides]. 1996.
161. 161. Hirsch K, Weaver D, Black L. Falcone J, MacLusky N. Inhibition of central nervous system aromatase activity: a mechanism for fenarimol-induced infertility in the male rat. Toxicol Appl Pharmacol. 1987;91:235-45.
162. 162. Laskey JW, Phelps PV. Effect of cadmium and other metal cations on in vitro Leydig cell testosterone production. Toxicol Appl Pharmacol. 1991;108:296-306.
163. 163. Laskey JW, Klinefelter GR, Kelce WR, Ewing LL. Effects of ethane dimethanesulfonate on adult and immature rabbit Leydig cells: comparison with EDS-treated rat Leydig cells. Biol Reprod. 1994;50:1151-60.
164. 164. Gray LE, Klinefelter G, Kelce W, et al. An in vivo and in vitro comparison of the effects of ethane dimethanesulfonate (EDS) on Leydig cell function in hamsters and rats. Toxicol Appl Pharmacol. 1995;130:248-56.
165. 165. Klinefelter GR, Hall PF, Ewing LL. Effect of luteinizing hormone deprivation in situ on steroidogenesis of rat Leydig cells purified by a multistep procedure. Biol Reprod. 1987;36: 769-83.
166. 166. Klinefelter GR, Laskey JW, Roberts NR. In vivo/in vitro effects of ethane dimethanesulphonate on Leydig cells of adult rats. Toxicol Appl Pharmacol. 1991;107:460-71.
167. 167. Klinefelter GR, Kelce WR, Hardy MP. The isolation and culture of Leydig cells from adult rats. In: Heindel J, Chapin R, eds. Methods in Toxicology, Vol. 3, Part A. San Diego, CA: Academic Press; 1993:166-81.
168. 168. Klinefelter G, Laskey J, Ferrell J, Roberts N, Suarez J. Chloroethyl-methanesulfonate-induced effects on the epididymis seem unrelated to altered Leydig cell function. Biol Reprod. 1994;51: 82-91.
169. 169. Klinefelter GR, Ewing LL. Optimizing testosterone production by purified adult rat Leydig cells in vitro. In Vitro Cell Dev Biol. 1988;24:545-9.
170. 170. Klinefelter GR, Ewing LL. Maintenance of testosterone production by purified adult rat Leydig cells for 3 days in vitro. In Vitro Cell Dev Biol. 1989;25:283-8.
171. 171. Hardy MP, Kelce WR, Klinefelter GR, Ewing LL. Differentiation of Leydig cell precursors in vitro: a role for androgen. Endocrinology. 1990;127:488-90.
172. 172. Klinefelter GR, Kelce WR. A comparison of Leydig cell responsiveness to hormonal and nonhormonal factors in vivo and in vitro. In: Russel L, Hardy M, eds. The Leydig Cell. Vienna, IL: Cache River Press; 1996:535-54.
173. 173. Steinberger A, Klinefelter G. Sensitivity of Sertoli and Leydig cells to xenobiotics in in vitro models. Reprod Toxicol. 1993;7: 23-37.
174. 174. Leung P, Armstrong D. Estrogen treatment of immature rats inhibits ovarian androgen production in vitro. J Endocrinol. 1979;104:1411-7.
175. 175. Laskey J, Berman E, Ferrell J. The use of cultured ovarian fragments to assess toxicant alterations in steroidogenesis in Sprague-Dawley rat. Reprod Toxicol. 1995;9:131-41.
176. 176. Armstrong DT, Dorrington JH, Robinson J. Effects of indomethacin and aminoglutethimide phosphate in vivo on luteinizing-hormone-induced alterations of cyclic adenosine monophosphate, prostaglandin F, and steroid levels in preovulatory rat ovaries. Can J Biochem. 1976;54:796-802.
177. 177. Hausler A, Schenkel L, Krahenbuhl C, Monnet G, Bhatnagar A. J Steroid Biochem. 1989;33:125-31.
178. 178. Piasek M, Laskey J. Acute cadmium exposure and ovarian steroidogenesis in cycling and pregnant rats. Reprod Toxicol. 1994;8:495-507.
179. 179. Berman E, Laskey J. Altered steroidogenesis in whole-ovary and adrenal culture in cycling rats. Reprod Toxicol. 1993;7: 349-58.
180. 180. Laskey J, Berman E. Steroidogenic assessment using ovary culture in cycling rats: effects of bis(2-diethylhexyl)phthalate on ovarian steroid production. Reprod Toxicol. 1993;7:25-33.